250 related articles for article (PubMed ID: 25127116)
1. Metformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro study.
Kobashigawa LC; Xu YC; Padbury JF; Tseng YT; Yano N
PLoS One; 2014; 9(8):e104888. PubMed ID: 25127116
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor mediated protection against doxorubicin-induced apoptosis in cardiomyocytes: the impact of high ambient glucose.
Yano N; Suzuki D; Endoh M; Tseng A; Stabila JP; McGonnigal BG; Zhao TC; Padbury JF; Tseng YT
Endocrinology; 2008 Dec; 149(12):6449-61. PubMed ID: 18719028
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effect of metformin on cardiotoxicity induced by doxorubicin via the MAPK and AMPK pathways.
Chen J; Zhang S; Pan G; Lin L; Liu D; Liu Z; Mei S; Zhang L; Hu Z; Chen J; Luo H; Wang Y; Xin Y; You Z
Life Sci; 2020 May; 249():117498. PubMed ID: 32142765
[TBL] [Abstract][Full Text] [Related]
4. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
[TBL] [Abstract][Full Text] [Related]
6. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
[TBL] [Abstract][Full Text] [Related]
7. p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts.
Sampaio SF; Branco AF; Wojtala A; Vega-Naredo I; Wieckowski MR; Oliveira PJ
Arch Toxicol; 2016 Jul; 90(7):1669-84. PubMed ID: 26318906
[TBL] [Abstract][Full Text] [Related]
8. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
9. The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity.
Timm KN; Tyler DJ
Cardiovasc Drugs Ther; 2020 Apr; 34(2):255-269. PubMed ID: 32034646
[TBL] [Abstract][Full Text] [Related]
10. PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades.
Liu D; Ma Z; Xu L; Zhang X; Qiao S; Yuan J
Aging (Albany NY); 2019 Nov; 11(22):10061-10073. PubMed ID: 31733141
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of phosphoinositide 3-kinase prevents sunitinib-induced cardiotoxicity in vitro and in vivo.
Li C; Zou R; Zhang H; Wang Y; Qiu B; Qiu S; Wang W; Xu Y
Arch Toxicol; 2019 Jun; 93(6):1697-1712. PubMed ID: 31025080
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.
Wang WC; Uen YH; Chang ML; Cheah KP; Li JS; Yu WY; Lee KC; Choy CS; Hu CM
BMC Complement Altern Med; 2012 Aug; 12():138. PubMed ID: 22920231
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway.
Liu MH; Lin XL; Guo DM; Zhang Y; Yuan C; Tan TP; Chen YD; Wu SJ; Ye ZF; He J
Mol Med Rep; 2016 Feb; 13(2):1281-6. PubMed ID: 26675978
[TBL] [Abstract][Full Text] [Related]
14. Metformin protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin cardiac system.
Asensio-López MC; Lax A; Pascual-Figal DA; Valdés M; Sánchez-Más J
Free Radic Biol Med; 2011 Nov; 51(10):1861-71. PubMed ID: 21907790
[TBL] [Abstract][Full Text] [Related]
15. Aerobic exercise, but not metformin, prevents reduction of muscular performance by AMPk activation in mice on doxorubicin chemotherapy.
de Lima EA; de Sousa LGO; de S Teixeira AA; Marshall AG; Zanchi NE; Neto JCR
J Cell Physiol; 2018 Dec; 233(12):9652-9662. PubMed ID: 29953589
[TBL] [Abstract][Full Text] [Related]
16. Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK.
Hu M; Ye P; Liao H; Chen M; Yang F
J Diabetes Res; 2016; 2016():2961954. PubMed ID: 27294149
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
18. Apelin-13 Reverses Bupivacaine-Induced Cardiotoxicity via the Adenosine Monophosphate-Activated Protein Kinase Pathway.
Ye Y; Cai Y; Xia E; Shi K; Jin Z; Chen H; Xia F; Xia Y; Papadimos TJ; Xu X; Liu L; Wang Q
Anesth Analg; 2021 Oct; 133(4):1048-1059. PubMed ID: 34524989
[TBL] [Abstract][Full Text] [Related]
19. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.
Saeedi R; Parsons HL; Wambolt RB; Paulson K; Sharma V; Dyck JR; Brownsey RW; Allard MF
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2497-506. PubMed ID: 18375721
[TBL] [Abstract][Full Text] [Related]
20. AP39, a novel mitochondria-targeted hydrogen sulfide donor ameliorates doxorubicin-induced cardiotoxicity by regulating the AMPK/UCP2 pathway.
Zhang B; Li Y; Liu N; Liu B
PLoS One; 2024; 19(4):e0300261. PubMed ID: 38568919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
